INSIGHTS ON DRUG DEVELOPMENT

• The 5 Ws Of A Human Factors Strategy

  A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.

• Automation Of 3D Intestinal Organoids Culture

  Gain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.

• Preclinical Immuno-Oncology Models For CAR T-Cell Therapy Development

  The following preclinical IND-enabling oncology studies conducted by scientists at Aragen over the past 10 years highlight the role of robust preclinical models in advancing the fight against cancer.

• Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs

  Explore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.

• 5 Key Considerations For Companies Outsourcing Process Development

  6/9/2025

  Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.

• Whitepaper: In Vivo Testing Of Nasal Dosage Forms

  5/7/2025

  Explore how innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.

• Accelerating The Regulatory Approval Process Of Biosimilars

  5/13/2025

  Leverage the power of pharmacodynamic biomarkers to streamline biosimilar development and accelerate regulatory approval with greater efficiency and confidence.

• Biophysical Tools For Biotherapeutic Development

  6/26/2025

  Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development.

• Topliss Sets In Drug Design Technical Notes For The Medicinal Chemist

  8/3/2023

  When considering new, innovative, and efficient drug design processes, you may want to review Professor J G Topliss's non-mathematical operational schemes for analogue design.